Compare ATRO & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRO | ALMR |
|---|---|---|
| Founded | 1968 | 2018 |
| Country | United States | United States |
| Employees | 2700 | N/A |
| Industry | Military/Government/Technical | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 1995 | 2026 |
| Metric | ATRO | ALMR |
|---|---|---|
| Price | $59.45 | $30.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $98.00 | $35.40 |
| AVG Volume (30 Days) | 457.5K | ★ 752.2K |
| Earning Date | 11-10-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 276.09 | N/A |
| EPS | ★ 1.31 | N/A |
| Revenue | ★ $862,128,000.00 | N/A |
| Revenue This Year | $19.84 | $59.79 |
| Revenue Next Year | $9.74 | $39.75 |
| P/E Ratio | $47.76 | ★ N/A |
| Revenue Growth | ★ 8.39 | N/A |
| 52 Week Low | $41.50 | $21.58 |
| 52 Week High | $99.89 | $39.61 |
| Indicator | ATRO | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 38.11 | 50.17 |
| Support Level | $56.20 | $23.52 |
| Resistance Level | $78.00 | $38.64 |
| Average True Range (ATR) | 2.76 | 2.51 |
| MACD | 0.24 | 0.62 |
| Stochastic Oscillator | 34.35 | 58.95 |
Astronics Corporation is a provider of technologies to the aerospace, defense, and electronics industries, offering high-performance electrical power generation and distribution systems, motion systems, lighting and safety systems, avionics products, systems certification, aircraft structures, and automated test systems. The company operates through two reportable segments, Aerospace and Test Systems. The Aerospace segment designs and manufactures products for the aerospace and defense industry and generates the majority of revenue, while the Test Systems segment designs, develops, manufactures, and maintains automated test systems for the aerospace and defense, communications, and mass transit industries. The company derives the majority of its revenue from the United States.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.